FDA panel says ‘no’ to experimental diet pill

FDA panel says ‘no’ to experimental diet pill
Federal health experts rejected a highly anticipated weight loss pill called lorcaserin that was thought to offer a safer way to shed pounds than older medications linked to dangerous side effects. Health – Food and Drug Administration – Anti-obesity medication – Weight loss – Arena Pharmaceutical
Read more on MSNBC

FDA Panel Rejects Diet Drug Lorcaserin
An FDA advisory panel has rejected lorcaserin, the latest weight loss drug to make a bid for the U.S. market.
Read more on WebMD

Add a Comment

Your email address will not be published. Required fields are marked *